1. Home
  2. EVAX vs CMND Comparison

EVAX vs CMND Comparison

Compare EVAX & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EVAX

Evaxion Biotech

HOLD

Current Price

$6.09

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$2.62

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
CMND
Founded
2008
2017
Country
Denmark
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.7M
5.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EVAX
CMND
Price
$6.09
$2.62
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.33
N/A
AVG Volume (30 Days)
100.4K
22.7M
Earning Date
11-06-2025
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,650,000.00
N/A
Revenue This Year
$128.77
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
132.17
N/A
52 Week Low
$1.20
$0.07
52 Week High
$12.15
$3.20

Technical Indicators

Market Signals
Indicator
EVAX
CMND
Relative Strength Index (RSI) 53.56 88.07
Support Level $5.72 $0.07
Resistance Level $6.70 $3.25
Average True Range (ATR) 0.51 0.10
MACD 0.07 0.28
Stochastic Oscillator 56.08 80.21

Price Performance

Historical Comparison
EVAX
CMND

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: